Search

Christopher Brian Mckinley

Examiner (ID: 13265)

Most Active Art Unit
3781
Art Unit(s)
3781
Total Applications
591
Issued Applications
270
Pending Applications
9
Abandoned Applications
315

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11662648 [patent_doc_number] => 20170151355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/431402 [patent_app_country] => US [patent_app_date] => 2017-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30441 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431402 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/431402
TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER Feb 12, 2017 Abandoned
Array ( [id] => 11850359 [patent_doc_number] => 20170224852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'BENZAZEPIN-1-OL-DERIVED PET LIGANDS WITH HIGH IN VIVO NMDA SPECIFICITY' [patent_app_type] => utility [patent_app_number] => 15/427952 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7014 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427952 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/427952
BENZAZEPIN-1-OL-DERIVED PET LIGANDS WITH HIGH IN VIVO NMDA SPECIFICITY Feb 7, 2017 Abandoned
Array ( [id] => 13899159 [patent_doc_number] => 20190038784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-07 [patent_title] => TAU PET IMAGING LIGANDS [patent_app_type] => utility [patent_app_number] => 16/073992 [patent_app_country] => US [patent_app_date] => 2017-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073992 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073992
TAU PET IMAGING LIGANDS Jan 31, 2017 Abandoned
Array ( [id] => 11850328 [patent_doc_number] => 20170224821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'IONIZING-RADIATION-RESPONSIVE COMPOSITIONS, METHODS, AND SYSTEMS' [patent_app_type] => utility [patent_app_number] => 15/412798 [patent_app_country] => US [patent_app_date] => 2017-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17216 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412798 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/412798
IONIZING-RADIATION-RESPONSIVE COMPOSITIONS, METHODS, AND SYSTEMS Jan 22, 2017 Abandoned
Array ( [id] => 13824095 [patent_doc_number] => 20190015532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII [patent_app_type] => utility [patent_app_number] => 16/070073 [patent_app_country] => US [patent_app_date] => 2017-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070073 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/070073
QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII Jan 12, 2017 Abandoned
Array ( [id] => 13840359 [patent_doc_number] => 20190023664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-24 [patent_title] => RADIOLABELED ERLOTINIB ANALOGS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/069546 [patent_app_country] => US [patent_app_date] => 2017-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069546 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/069546
Radiolabeled erlotinib analogs and uses thereof Jan 11, 2017 Issued
Array ( [id] => 15345209 [patent_doc_number] => 20200010496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => METHOD FOR PREPARING TRICARBONYL TECHNETIUM-99M INTERMEDIATE [patent_app_type] => utility [patent_app_number] => 16/464919 [patent_app_country] => US [patent_app_date] => 2016-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464919 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/464919
Method for preparing tricarbonyl technetium-99m intermediate Dec 27, 2016 Issued
Array ( [id] => 16341739 [patent_doc_number] => 20200306389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => RADIOLABELLED mGluR2/3 PET LIGANDS [patent_app_type] => utility [patent_app_number] => 16/061437 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8307 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061437 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/061437
Radiolabelled mGluR2/3 pet ligands Dec 15, 2016 Issued
Array ( [id] => 13729923 [patent_doc_number] => 20180369429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => RADIOLABELLED mGluR2/3 PET LIGANDS [patent_app_type] => utility [patent_app_number] => 16/061674 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061674 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/061674
Radiolabelled mGluR2/3 PET ligands Dec 15, 2016 Issued
Array ( [id] => 11542565 [patent_doc_number] => 20170096390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 15/380216 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15632 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380216 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/380216
FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES Dec 14, 2016 Abandoned
Array ( [id] => 16053371 [patent_doc_number] => 20200188540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING [patent_app_type] => utility [patent_app_number] => 16/062756 [patent_app_country] => US [patent_app_date] => 2016-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8592 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062756 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/062756
CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING Dec 13, 2016 Abandoned
Array ( [id] => 11729215 [patent_doc_number] => 20170190658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'IMAGING AGENTS' [patent_app_type] => utility [patent_app_number] => 15/367856 [patent_app_country] => US [patent_app_date] => 2016-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15506 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367856 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/367856
IMAGING AGENTS Dec 1, 2016 Abandoned
Array ( [id] => 16251323 [patent_doc_number] => 20200260697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => METHODS OF MOUSE CLINICAL TRIAL [patent_app_type] => utility [patent_app_number] => 16/464275 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464275 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/464275
METHODS OF MOUSE CLINICAL TRIAL Nov 28, 2016 Abandoned
Array ( [id] => 11618412 [patent_doc_number] => 20170128599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY' [patent_app_type] => utility [patent_app_number] => 15/358787 [patent_app_country] => US [patent_app_date] => 2016-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18933 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358787 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/358787
FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY Nov 21, 2016 Abandoned
Array ( [id] => 13586665 [patent_doc_number] => 20180344881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => FORMULATIONS FOR 2-HETEROARYL SUBSTITUTED BENZOFURANS [patent_app_type] => utility [patent_app_number] => 15/777640 [patent_app_country] => US [patent_app_date] => 2016-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -60 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777640 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/777640
FORMULATIONS FOR 2-HETEROARYL SUBSTITUTED BENZOFURANS Nov 20, 2016 Abandoned
Array ( [id] => 11690816 [patent_doc_number] => 20170166531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-15 [patent_title] => '2-ALKOXY-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/347394 [patent_app_country] => US [patent_app_date] => 2016-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18299 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347394 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/347394
2-alkoxy-11-hydroxyaporphine derivatives and uses thereof Nov 8, 2016 Issued
Array ( [id] => 14360043 [patent_doc_number] => 10301308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Azetidine derivatives for tau imaging [patent_app_type] => utility [patent_app_number] => 15/763608 [patent_app_country] => US [patent_app_date] => 2016-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9110 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763608 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/763608
Azetidine derivatives for tau imaging Nov 3, 2016 Issued
Array ( [id] => 16518740 [patent_doc_number] => 10869942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-22 [patent_title] => Method [patent_app_type] => utility [patent_app_number] => 15/771152 [patent_app_country] => US [patent_app_date] => 2016-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14227 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771152 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/771152
Method Oct 25, 2016 Issued
Array ( [id] => 16190765 [patent_doc_number] => 20200231614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY [patent_app_type] => utility [patent_app_number] => 15/769865 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769865 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/769865
PSMA TARGETED RADIOHALOGENATED UREAS FOR CANCER RADIOTHERAPY Oct 20, 2016 Abandoned
Array ( [id] => 14040901 [patent_doc_number] => 20190076557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => HYALURONAN SN-117M COLLOID FOR RADIOSYNOVIORTHESIS AND SYMPTOMATIC THERAPY RELATED APPLICATIONS [patent_app_type] => utility [patent_app_number] => 15/765559 [patent_app_country] => US [patent_app_date] => 2016-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765559 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/765559
HYALURONAN SN-117M COLLOID FOR RADIOSYNOVIORTHESIS AND SYMPTOMATIC THERAPY RELATED APPLICATIONS Oct 4, 2016 Abandoned
Menu